Ocean Biomedical, Inc.

Ocean Biomedical, Inc. (Nasdaq: OCEA) is a biopharmaceutical company that completed its business combination with Lux Health Tech Acquisition Corp., a SPAC sponsored by Lux Capital, in February 2023. The blank-check vehicle originally priced its IPO in 2021, targeting the life sciences and healthcare sector. Ocean Biomedical, founded on research originating from Brown University, is developing a pipeline of therapeutics across oncology, pulmonary fibrosis, and infectious disease. The company filed an 8-K with the SEC on April 1, 2025, and continues to trade as a post-merger public entity. Visit SpacDesk and sign up for full access to Ocean Biomedical's filing history, deal timeline, and live SPAC data.